| # | Drug | Count |
|---|---|---|
| 0 | PANTOPRAZOLE SODIUM | 4 |
| 1 | SITAGLIPTIN | 4 |
| 2 | SORAFENIB | 4 |
| 3 | ASPIRIN | 3 |
| 4 | ASPIRIN 325 MG | 3 |
| 5 | ASPIRIN 81 MG | 3 |
| 6 | BEVACIZUMAB | 3 |
| 7 | DOCUSATE SODIUM | 3 |
| 8 | ERGOCALCIFEROL | 3 |
| 9 | EXENATIDE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BISACODYL 5MG | 1 | 0.0011 |
| 1 | TALIMOGENE LAHERPAREPVEC | 1 | 0.0006 |
| 2 | DAPRODUSTAT | 1 | 0.0005 |
| 3 | MARC GLASSMAN | 1 | 0.0003 |
| 4 | DESMOPRESSIN ACETATE | 1 | 0.0003 |
| 5 | DOCUSATE SODIUM AND SENNOSIDES | 1 | 0.0002 |
| 6 | DOCUSATE CALCIUM | 1 | 0.0002 |
| 7 | DOCUSATE SODIUM SENNOSIDES | 1 | 0.0002 |
| 8 | CABERGOLINE | 1 | 0.0002 |
| 9 | SORAFENIB | 4 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 6 |
| 1 | Proton Pump Inhibitor [EPC] | 6 |
| 2 | Corticosteroid [EPC] | 5 |
| 3 | GLP-1 Receptor Agonist [EPC] | 4 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 4 |
| 5 | Opioid Agonist [EPC] | 4 |
| 6 | Platinum-based Drug [EPC] | 4 |
| 7 | Alkylating Drug [EPC] | 3 |
| 8 | Aromatase Inhibitor [EPC] | 3 |
| 9 | Microtubule Inhibitor [EPC] | 3 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 1 | Ergot Derivative [EPC] | 1 | 0.0002 |
| 2 | Provitamin D2 Compound [EPC] | 3 | 0.0001 |
| 3 | Stimulant Laxative [EPC] | 1 | 0.0001 |
| 4 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Aluminum Complex [EPC] | 1 | 0.0000 |
| 6 | Methylxanthine [EPC] | 2 | 0.0000 |
| 7 | Nitrate Vasodilator [EPC] | 3 | 0.0000 |
| 8 | Aromatase Inhibitor [EPC] | 3 | 0.0000 |
| 9 | Integrin Receptor Antagonist [EPC] | 2 | 0.0000 |